MMP9 and metabolic dysfunction-associated steatotic liver disease: Indeed, serum concentrations of MMP2, MMP9, TIMP1, TIMP2, MMP7, TGF-β1 and -β2 were found to be significantly higher in NAFLD patients compared to controls, yet these markers are unable to distinguish between steatosis and steatohepatitis.